Immunomic TherapeuticsImmunomic Therapeutics
Immunomic TherapeuticsImmunomic Therapeutics
  • Pipeline
  • Partnerships
  • Clinical Trials
    • ITI-1000: Glioblastoma Multiforme
    • ITI-1001: Glioblastoma Multiforme
    • ITI-3000: Merkel Cell Carcinoma
  • Team
  • Careers
  • Media
  • Contact Us
  • Pipeline
  • Partnerships
  • Clinical Trials
    • ITI-1000: Glioblastoma Multiforme
    • ITI-1001: Glioblastoma Multiforme
    • ITI-3000: Merkel Cell Carcinoma
  • Team
  • Careers
  • Media
  • Contact Us

Blog

  • Articles
  • Blog
  • Events
  • Featured
  • Highlights
  • Posters
  • Press
  • Press Releases
  • Uncategorized

2019 SITC ASCO Clinical Immuno Oncology Symposium Feb. 28-Mar. 2, San Francisco

by Sara Solt in Events, Past Events
The ASCO-SITC Clinical Immuno-Oncology Symposium is a three-day meeting focused on clinical and translational research in immuno-oncology and the implications for clinical care. ​ https://immunosym.org/
Read More

Immunomic Therapeutics Senior Director of Corporate Development to Present at Precision Lung Cancer World R&D Summit

by Sara Solt in Press, Press Releases
Immunomic Therapeutics Senior Director of Corporate Development to Present at Precision Lung Cancer World R&D Summit Discussion of lysosomal targeting technology as applied in cancer immunotherapy October 26, 2018 07:30 ...
Read More

Immunomic Therapeutics CEO to Present at NYC Oncology Investor Conference

by Sara Solt in Press, Press Releases
Immunomic Therapeutics CEO to Present at NYC Oncology Investor Conference To Discuss UNITE Technology Application in Oncology October 23, 2018 07:00 AM Eastern Daylight Time   NEW YORK--(BUSINESS WIRE)--Immunomic Therapeutics, ...
Read More

Immunomic Therapeutics CEO to Join Panel at 18th Annual Biotech in Europe Forum

by Sara Solt in Press Releases
Panel to Highlight Advanced Therapeutics for Oncology October 03, 2018 12:00 AM Eastern Daylight Time BASEL, Switzerland--(BUSINESS WIRE)--Tomorrow, William Hearl, Ph.D., Chief Executive Officer (CEO) of Immunomic Therapeutics, Inc., will ...
Read More

ICYMI…Immunomic Therapeutics Presents at the 2018 BIO Investor Forum…Watch webcast here

by Sara Solt in Featured, Past Events, Press Releases
Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company presented at the 2018 BIO Investor Forum held in San Francisco, CA on October 17-18. William Hearl, Ph.D., Immunomic’s Founder ...
Read More

Immunomic Therapeutics, Inc. Founder and CEO Bill Hearl Joins Rich Bendis for BioTalk Podcast

by Sara Solt in Featured, Highlights, Press
 Immunomic Therapeutics, Inc. Founder and CEO Bill Hearl Joins Rich Bendis for BioTalk Click to hear the interview: Bill Hearl Q&A Dr. Bill Hearl is the Founder and Chief Executive Officer ...
Read More

Q&A with Dr. Heiland, Sr. VP R&D

by Sara Solt in Blog, Featured, Highlights, Press
Our very own Dr. Heiland has been featured on BioBuzz.  Click below to read the full Q&A Interview, as Dr. Heiland discusses our technology platform name change to UNITE and ...
Read More

Immunomic Therapeutics CEO at Outsourcing in Clinical Trials Mid-Atlantic

by Sara Solt in Press Releases
ITI Founder & CEO will discuss new developments in cancer immunotherapy October 01, 2018 05:02 PM Eastern Daylight Time ROCKVILLE, Md. (BUSINESSWIRE)--Bill Hearl, Ph.D., Founder and Chief Executive Officer (CEO) ...
Read More

The Use and Misuse of Cancer Life Expectancy Statistics

by Sara Solt in Articles, Blog, Featured, Highlights
Please read the article authored by ITI titled, “The Use and Misuse of Cancer Life Expectancy Statistics” which explores how GBM patients adjust and deal with dire life expectancy statistics. ...
Read More

23rd Annual Meeting and Education Day for the Society for Neuro-Oncology, Nov. 15-18, New Orleans, LA

by Sara Solt in Events, Past Events
23rd ANNUAL SCIENTIFIC MEETING AND EDUCATION DAY OF THE SOCIETY FOR NEURO-ONCOLOGY Marriott Hotel, New Orleans, Louisiana Thursday, November 15, 8:00am - Sunday, November 18, 1:00pm Click here to view the preliminary ...
Read More

24th Annual International Partnering Conference BIO Europe, Nov. 5-7, Copenhagen, Denmark

by Sara Solt in Events, Past Events
The 24th annual BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry. Delegates from all parts of the biotechnology value chain come to BIO-Europe to quickly identify, engage ...
Read More

BIO Investor Forum, Oct. 17-18, San Francisco, CA

by Sara Solt in Events, Past Events
The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The event features plenary sessions, business roundtables ...
Read More
1
2345678910111213
…1415161718…
19202122232425
26
← Previous pageNext page →

Content
  • Pipeline
  • Partnerships
  • Team
  • Media
  • Contact Us
Careers
  • Careers
  • Compensation & Benefits
  • Culture & Beliefs
Policies
  • Expanded Access Policy
  • Privacy Policy
Social
  • Facebook
  • X / Twitter
  • Youtube
Telephone

+1.301.968.3501

Address

15010 Broschart Road

Rockville, MD 20850

© 2020 Immunomic Therapeutics, Inc. All Rights Reserved.